Accelerating Parkinson's drug development: The International Linked Clinical Trials initiative
In 2012, Cure Parkinson’s joined forces with Van Andel Institute (VAI) to hold the first international Linked Clinical Trials (iLCT) meeting in Grand Rapids, Michigan. The Committee has since met annually to evaluate and prioritise drugs for clinical trial in Parkinson’s, a review of which has now been published in the Journal of Parkinson’s Disease.
Learn more![](https://cureparkinsons.org.uk/wp-content/uploads/2024/04/MG_2507-e1712833330815-1000x800.jpg)
Parkinson’s and dementia: improving cognitive measures to enable better treatments
Recently, several international Parkinson’s and Dementia with Lewy Bodies (DLB) advocacy organizations, including Cure Parkinson’s, held a roundtable to discuss the development of better tools for measuring cognitive changes in people with Parkinson’s and DLB.
Pedaling from Peckham to Penzance, for Parkinson’s
Cure Parkinson’s supporters take on 500km charity bike ride to raise funds and awareness for our research, with the team raising more than £31k for us! Brothers Max and Joe, and brother-in-law Paddy, organised this epic bike ride from Peckham, London to Penzance, Cornwall to…
Our two newest pre-clinical research projects
Cure Parkinson’s is pleased to announce the funding for two new projects as part of our annual iLCT Pipeline Research Acceleration Grant Programme.
Cure Parkinson’s Fundraising Heroes: June 2024
Find out what some of Cure Parkinson’s supporters have been up to recently. The London to Brighton bike ride 15 Cure Parkinson’s fundraisers took part in the 2024 London to Brighton charity bike ride, setting off from Clapham Common, London to cycle 54 miles to…
Cure Parkinson’s BBC Radio 4 Appeal with Paul Mayhew-Archer
TV writer, comedian, and Movers & Shakers podcaster Paul Mayhew-Archer presents a BBC Radio 4 Appeal on behalf of Cure Parkinson’s. This three minute, weekly programme highlights the work of a charity and is a fantastic opportunity to raise money and awareness for our research…